Senior Director, Lung and HNSCC Clinical Intelligence & RWE Strategy
AstraZeneca · Cambridge, Massachusetts, United States of America · Global
Pharma Strategy
–
Not yet analysed
Demand90
Career growth90
Healthcare fit85
Remote potential60
5-year outlook
Competitive executive compensation typical for senior pharma strategy roles, with strong growth potential as RWE and AI integration expand in drug development.
Clinical license
Not required
Applicant reach
narrow
Seniority
senior
Employment type
full-time
Date found
2026-09-24
Intelligence details
Why this is worth applying to
For clinicians with deep oncology and RWE experience, this is a high-impact pivot into pharma strategy. However, it's a senior leadership role requiring proven track record in evidence generation and cross-functional leadership.
Who should apply
Oncologists, clinical researchers with RWE expertise, and those with experience in clinical development and biomarker strategy.
CV angle
Highlight clinical expertise in lung/HNSCC, experience with real-world data and evidence generation, strategic leadership in clinical development, and ability to translate scientific questions into actionable evidence plans.
Skills to highlight
- Real-world evidence (RWE)
- Clinical development strategy
- Oncology expertise
- Biomarker strategy
- Cross-functional leadership
- AI/ML awareness
- Regulatory and market access understanding
Role summary
Lead the Lung and HNSCC Clinical Intelligence & RWE Strategy capability at AstraZeneca, setting the evidence agenda across the product lifecycle and integrating AI to accelerate decision-making.
We publish our own intelligence summary, never the full job description. Always confirm details with the employer when you apply.